$8.18
0.313.94%
Last update: Nov 9, 4:44 PM

The average analyst price target for Atara Biotherapeutics is $22.42, 174.1% above the current price. Of 7 analysts, 3 rate it Buy, 3 Hold and 1 Sell. Targets range from $10 to $57.50. The latest change came on May 18, 2026, when Freedom Broker upgraded Atara Biotherapeutics from Sell to Hold and moved its price target from $4 to $10.
Price Target Range — 10 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months